• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.无创胎儿三体(NIFTY)检测的临床应用——早期经验
J Matern Fetal Neonatal Med. 2012 Oct;25(10):1856-9. doi: 10.3109/14767058.2012.678442. Epub 2012 Apr 28.
2
[Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].[母体血浆中游离胎儿DNA检测在染色体异常产前诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):808-12.
3
[Non-invasive fetal trisomy (NIFTY) test in prenatal diagnosis].[无创胎儿三体(NIFTY)检测在产前诊断中的应用]
Ginekol Pol. 2014 Apr;85(4):300-3. doi: 10.17772/gp/1727.
4
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
5
[Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].[利用孕妇血清中游离胎儿DNA对最常见非整倍体进行无创产前诊断——初步结果]
Ginekol Pol. 2014 Mar;85(3):208-13. doi: 10.17772/gp/1715.
6
Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.IONA检测的临床评估:一种用于21、18和13三体综合征的非侵入性产前筛查检测
Ultrasound Obstet Gynecol. 2016 Feb;47(2):188-93. doi: 10.1002/uog.15791. Epub 2015 Dec 28.
7
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.母体外周血游离 DNA 检测筛查三体的结果失败:后果分析。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25.
8
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.在常规筛查的早孕期人群中进行胎儿三体的非侵入性产前检测。
Am J Obstet Gynecol. 2012 Nov;207(5):374.e1-6. doi: 10.1016/j.ajog.2012.08.033. Epub 2012 Sep 19.
9
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.孕10 - 11周时通过母体血液游离DNA分析筛查21 -三体、18 -三体和13 -三体,以及孕11 - 13周时进行联合检测。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):36-41. doi: 10.1002/uog.14664. Epub 2014 Nov 20.
10
Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.无创性胎儿三体检测(NIFTY):一种先进的非侵入性产前诊断方法,用于检测胎儿常染色体和性染色体非整倍体。
BMC Med Genomics. 2012 Dec 1;5:57. doi: 10.1186/1755-8794-5-57.

引用本文的文献

1
Application of Digital Polymerase Chain Reaction (dPCR) in Non-Invasive Prenatal Testing (NIPT).数字聚合酶链反应(dPCR)在无创产前检测(NIPT)中的应用。
Biomolecules. 2025 Mar 1;15(3):360. doi: 10.3390/biom15030360.
2
NIPT Integration as a Patient-Paid Prenatal Screening Option-Observations and Challenges from a Bulgarian Genetic Counseling Center.作为患者自费产前筛查选项的无创产前检测整合——来自保加利亚遗传咨询中心的观察与挑战
Med Sci (Basel). 2024 Dec 29;13(1):3. doi: 10.3390/medsci13010003.
3
Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing.无创产前检测识别出风险的妊娠的处理与管理
J Pers Med. 2024 Mar 29;14(4):366. doi: 10.3390/jpm14040366.
4
Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.全基因组非侵入性产前检测在产前筛查算法中的应用:来自 12700 例妊娠的临床经验。
BMC Pregnancy Childbirth. 2022 Aug 9;22(1):633. doi: 10.1186/s12884-022-04966-8.
5
Effective Identification of Maternal Malignancies in Pregnancies Undergoing Noninvasive Prenatal Testing.在接受无创产前检测的孕妇中有效识别母体恶性肿瘤
Front Genet. 2022 Feb 10;13:802865. doi: 10.3389/fgene.2022.802865. eCollection 2022.
6
Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples.基于临床验证的 NIPT 样本对 NIPT 非整倍体检测软件工具的系统评估。
PLoS Comput Biol. 2021 Dec 20;17(12):e1009684. doi: 10.1371/journal.pcbi.1009684. eCollection 2021 Dec.
7
Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000-2019) and Israel (2011-2019).丹麦(2000 - 2019年)和以色列(2011 - 2019年)的无创产前筛查与侵入性检测趋势
Front Med (Lausanne). 2021 Nov 17;8:768997. doi: 10.3389/fmed.2021.768997. eCollection 2021.
8
Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study.全面的非侵入性产前筛查用于患有遗传性疾病高风险的妊娠:一项前瞻性、多中心研究方案。
BMJ Open. 2021 Aug 27;11(8):e053617. doi: 10.1136/bmjopen-2021-053617.
9
Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review.药物致畸性的遗传易感性:一项系统文献综述。
Front Genet. 2021 Apr 27;12:645555. doi: 10.3389/fgene.2021.645555. eCollection 2021.
10
Analysis of 17,428 pregnant women undergoing non-invasive prenatal testing for fetal chromosome in Northeast China.对中国东北地区 17428 名接受胎儿染色体非侵入性产前检测的孕妇进行分析。
Medicine (Baltimore). 2021 Feb 12;100(6):e24740. doi: 10.1097/MD.0000000000024740.

本文引用的文献

1
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.母体血浆 DNA 测序可靠地鉴定出 18 三体、13 三体和唐氏综合征:一项国际合作研究。
Genet Med. 2012 Mar;14(3):296-305. doi: 10.1038/gim.2011.73. Epub 2012 Feb 2.
2
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011.使用大规模平行测序技术(MPS)进行唐氏综合征的产前检测:2011年10月24日,一个委员会代表国际产前诊断学会理事会发布的快速反应声明
Prenat Diagn. 2012 Jan;32(1):1-2. doi: 10.1002/pd.2919. Epub 2012 Jan 24.
3
Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.通过母体血浆DNA测序对常见胎儿染色体非整倍体进行无创产前诊断。
J Matern Fetal Neonatal Med. 2012 Aug;25(8):1370-4. doi: 10.3109/14767058.2011.635730. Epub 2012 Feb 24.
4
Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake.非侵入性产前诊断:孕妇的兴趣和预期接受度。
Prenat Diagn. 2011 Dec;31(13):1292-9. doi: 10.1002/pd.2888. Epub 2011 Oct 26.
5
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing.母体外周血游离 DNA 测序在胎儿三体 18 及三体 13 非侵入性产前诊断中的应用
PLoS One. 2011;6(7):e21791. doi: 10.1371/journal.pone.0021791. Epub 2011 Jul 6.
6
Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood.利用母体血液中游离胎儿 DNA 的大规模平行 DNA 测序技术对胎儿染色体异常的最佳检测。
Clin Chem. 2011 Jul;57(7):1042-9. doi: 10.1373/clinchem.2011.165910. Epub 2011 Apr 25.
7
Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.鉴定颈项透明层增厚且染色体核型正常胎儿的亚微结构染色体异常。
Ultrasound Obstet Gynecol. 2011 Sep;38(3):314-9. doi: 10.1002/uog.8988. Epub 2011 Aug 10.
8
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.母体外周血游离 DNA 测序在胎儿 21 三体非侵入性检测中的临床应用研究
Am J Obstet Gynecol. 2011 Mar;204(3):205.e1-11. doi: 10.1016/j.ajog.2010.12.060. Epub 2011 Feb 18.
9
Screening for fetal aneuploidies at 11 to 13 weeks.11-13 孕周胎儿非整倍体筛查。
Prenat Diagn. 2011 Jan;31(1):7-15. doi: 10.1002/pd.2637.
10
First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases.香港孕早期21三体综合征联合筛查:前10000例的筛查结果
J Matern Fetal Neonatal Med. 2009 Apr;22(4):300-4. doi: 10.1080/14767050802430842.

无创胎儿三体(NIFTY)检测的临床应用——早期经验

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

作者信息

Lau Tze Kin, Chan Mei Ki, Lo Pui Shan Salome, Chan Hon Yee Connie, Chan Wai Sze Kim, Koo Tik Yee, Ng Hoi Yan Joyce, Pooh Ritsuko K

机构信息

Fetal Medicine Centre, Paramount Clinic, Hong Kong.

出版信息

J Matern Fetal Neonatal Med. 2012 Oct;25(10):1856-9. doi: 10.3109/14767058.2012.678442. Epub 2012 Apr 28.

DOI:10.3109/14767058.2012.678442
PMID:22471583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3483059/
Abstract

OBJECTIVE

To report the initial experience of noninvasive prenatal diagnosis of fetal Down syndrome (The NIFTY test) in a clinical setting.

METHODS

The NIFTY test was offered as a screening test for fetal Down syndrome to pregnant women with a singleton pregnancy at 12 weeks of gestation or beyond. A satisfaction questionnaire was sent to the first 400 patients.

RESULTS

During a 6-month period, 567 NIFTY tests were performed. Over 90% of those studied were ethnic Chinese, and the mean age of the women studied was 36 years. The test was performed at 12-13 weeks of gestation in 49.21%. The median reporting time was 9 days. The test was positive for trisomy 21 in eight cases, and for trisomy 18 in 1 case; all were confirmed by fetal karyotyping. There was no false-positive result. Of the questionnaires, 182 completed responses were received. Over 95% had complete or almost complete resolution of anxiety. Except for one, all were satisfied with the NIFTY test, and all indicated that they would recommend the test to their friends.

CONCLUSION

The NIFTY test was a highly specific test. Unnecessary invasive tests and associated fetal losses could be avoided in almost all women who have a normal fetus.

摘要

目的

报告在临床环境中进行胎儿唐氏综合征无创产前诊断(NIFTY检测)的初步经验。

方法

向妊娠12周及以上的单胎妊娠孕妇提供NIFTY检测作为胎儿唐氏综合征的筛查试验。向首批400名患者发送了满意度调查问卷。

结果

在6个月的时间里,共进行了567次NIFTY检测。超过90%的受检者为华裔,受检女性的平均年龄为36岁。49.21%的检测在妊娠12 - 13周时进行。中位报告时间为9天。21三体综合征检测呈阳性8例,18三体综合征检测呈阳性1例;所有结果均经胎儿核型分析证实。无假阳性结果。共收到182份问卷回复。超过95%的人焦虑完全或几乎完全缓解。除1人外,所有人对NIFTY检测都很满意,并且都表示会向朋友推荐该检测。

结论

NIFTY检测是一项高度特异的检测。几乎所有胎儿正常的女性都可避免不必要的侵入性检测及相关的胎儿丢失。